Sign Out
Hypersensitivity to flurbiprofen, aspirin, other NSAIDs, other lozenge ingredients or any of the excipients in the product.
Patients who have previously shown hypersensitivity reactions (e.g. bronchospasm, asthma, rhinitis, angioedema, or urticaria) in response to aspirin or other non-steroidal anti-inflammatory drugs.
Active, existing or history of peptic ulcerations/haemorrhage (two or more distinct episodes of proven ulceration or bleeding) and intestinal ulceration.
History of gastrointestinal bleeding or perforation, severe colitis, haemorrhagic or haematopoietic disorders related to previous NSAIDs therapy.
Severe heart failure, renal failure or hepatic failure (see Precautions).
Last trimester of pregnancy (see Use in Pregnancy & Lactation).
Oromucosal Spray: Children and adolescents below 18 years.
Continue with Google